Business Context and Reporting Period
This Form 8-K Current Report is filed by GoodRx Holdings, Inc. on March 14, 2026. The report discloses a change in the Company's independent registered public accounting firm.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance regarding the external auditor.
Material Changes
- Appointment of New Auditor: The Audit and Risk Committee appointed KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
- Dismissal of Prior Auditor: PricewaterhouseCoopers LLP (PwC) was dismissed as the independent registered public accounting firm.
- Audit History: PwC's audit reports for the years ended December 31, 2025, and 2024, contained no adverse opinions, disclaimers, or qualifications.
- Disagreements: There were no disagreements with PwC regarding accounting principles, financial statement disclosures, or auditing scope during the fiscal years 2024-2025 or the interim period through March 14, 2026.
- Consultations: The Company did not consult with KPMG regarding accounting principles or audit opinions prior to their appointment.
Guidance, Outlook, and Risks
The filing does not contain financial guidance, management outlook, or specific risk factors related to operations. The primary disclosure is the procedural change in audit oversight. PwC has been requested to provide a letter to the SEC confirming their agreement with the statements in this report; this letter is filed as Exhibit 16.1.
Investor Verification Checklist
- Verify the content of the Letter from PricewaterhouseCoopers LLP (Exhibit 16.1) to confirm no undisclosed disagreements exist.
- Review the competitive proposal process details if available in other filings to understand the rationale for the auditor switch.
- Monitor future filings for the initial audit report issued by KPMG for the fiscal year ending December 31, 2026.